CNR1 and allergic disease: The endocannabinoids and cannabinoid receptor (CB) 1, which corresponds to CNR1 gene signalling, may play a potent inhibitory role in human mast cell degranulation and activation in the airway mucosa and skin, suggesting that targeting the ECS in these tissues might well represent a novel strategy for the treatment of allergy.